City

Condition

Follicular Lymphoma ( FL) (1)

Marginal Zone Lymphoma (MZL) (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Incyte Corporation (1)

Collaborator

Intervention

obinutuzumab (1)

parsaclisib (1)

rituximab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

follicular lymphoma ( fl)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Follicular Lymphoma ( FL), Marginal Zone Lymphoma (MZL) Trial (parsaclisib, rituximab, obinutuzumab)

Withdrawn

Follicular Lymphoma ( FL)
Marginal Zone Lymphoma (MZL)

parsaclisib
+2 more

(no location specified)

Jul 14, 2022